• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

4 HCV reps in Texas quit!!!!!!!

























The turnover there should be epic prior to the launch of the mixed matched combo. Glad I turned it down and went elsewhere. Good luck to those who hang on. Sometimes you just gotta do what you gotta do for a job.
 
































Upper management needs to change its primary care mind set!!! This is not Biotech its primary care. Look in the mirror RM's, NSD. This is not what you promised!!

Since very few of them have worked in specialty, they probably have no idea of what they were speaking about.

You are a PC rep with a HCV title. STFU with your constant fucking whining. It's a great, high paying job with a shitload of upside. Get on the bus.